Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,779 public trials 700 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

NCT02348216

Conditions
Hemic and Lymphatic Diseases, High Grade B-cell Lymphoma (HGBCL), Immune System Diseases, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego (UCSD) La Jolla, California, United States
  • Stanford University Palo Alto, California, United States
View all 36 locations
View Trial Details
Completed

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin

NCT00268853

Conditions
Diffuse Large-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Bay Medical Oncology & Hematology Concord, California, United States
  • Hazel Hawkins Hospital, Dept. of Medical Oncology Hollister, California, United States
  • UCSD Moore's Cancer Center-Blood & Marrow Transplantation Division La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 75 locations
View Trial Details
Completed

Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma

NCT01492088

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • Aurora, Colorado, United States
  • Kansas City, Missouri, United States
  • New York, United States
  • Houston, Texas, United States
View all 18 locations
View Trial Details
Completed

Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

NCT02073097

Conditions
Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

NCT03721172

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations
  • Total Skin & Beauty Dermatology Center Birmingham, Alabama, United States
  • Johnson Dermatology Clinic Fort Smith, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology Rogers, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 64 locations
View Trial Details

Related conditions